Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Bhagiradha Chemicals & Industries Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,120.19 | 933.15 | 576.04 |
| Accumulated Depreciation Total | -130.73 | -99.88 | -86.45 |
| Other Liabilities Total | 1.45 | 1.01 | 0.93 |
| Long Term Debt | 153.14 | 30.05 | 16.94 |
| Common Stock Total | 12.97 | 12.97 | 10.41 |
| Other Current Assets Total | 3.55 | 0.99 | 0.99 |
| Prepaid Expenses | 3.28 | 4.03 | 2.31 |
| Total Assets | 1,120.19 | 933.15 | 576.04 |
| Current Portof LT Debt/Capital Leases | 9.95 | 9.42 | 5.66 |
| Additional Paid-In Capital | 473.97 | 473.97 | 220.17 |
| Cash | 15.74 | 1.7 | 4.92 |
| Total Equity | 698.32 | 682.22 | 413.71 |
| Retained Earnings(Accumulated Deficit) | 211.38 | 195.28 | 183.14 |
| Total Common Shares Outstanding | 12.97 | 12.97 | 10.41 |
| Property/Plant/Equipment Total-Gross | 803.41 | 630.85 | 365.86 |
| Tangible Book Valueper Share Common Eq | 53.63 | 52.38 | 39.54 |
| Total Liabilities | 421.87 | 250.93 | 162.33 |
| Total Debt | 234.49 | 88.76 | 61.49 |
| Short Term Investments | 0 | 0 | 38.49 |
| Cashand Short Term Investments | 15.74 | 28.8 | 48.42 |
| Total Receivables Net | 267.08 | 211.05 | 116.63 |
| Notes Payable/Short Term Debt | 69.05 | 46.06 | 38.68 |
| Deferred Income Tax | 19.39 | 21.39 | 18.73 |
| Accounts Receivable-Trade Net | 204.97 | 174.11 | 107.34 |
| Property/Plant/Equipment Total-Net | 672.68 | 530.97 | 279.41 |
| Total Current Liabilities | 245.54 | 195.26 | 125.52 |
| Total Inventory | 146.84 | 130.01 | 111.93 |
| Accounts Payable | 138.09 | 93.18 | 65.25 |
| Other Currentliabilities Total | 28.45 | 46.6 | 15.93 |
| Total Long Term Debt | 155.49 | 33.28 | 17.15 |
| Intangibles Net | 2.85 | 3.08 | 2.24 |
| Other Long Term Assets Total | 6.67 | 5.79 | 6.16 |
| Note Receivable-Long Term | 1.5 | 18.44 | 7.21 |
| Total Current Assets | 436.49 | 374.88 | 280.28 |
| Capital Lease Obligations | 2.35 | 3.23 | 0.21 |
| Cash Equivalents | Not available | 27.1 | 5 |
| Long Term Investments | Not available | 0 | 0.74 |
| Other Equity Total | Not available | Not available | 0 |
Debt 5Yr CAGR %30.4
Operating Margin 12m8.77
Operating Margin 5y Avg9.4
Net Profit Margin 12m4.53
Net Profit Margin 5y5.65
Dividend Yield %0.05
Price to Sale Ratio6.60
Overall RiskHigh risk
Board Risk49.64
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Bhagiradha Chemicals Schedules Virtual Analyst and Institutional Investor Meetings for June 9 TipRanks
Bhagiradha Chemicals schedules analyst meet on June 9 scanx.trade
Bhagiradha Chemicals Extends Rs 30 Crore Corporate Guarantee for Subsidiary Loan TipRanks
Bhagiradha Chemicals & Industries Ltd is Rated Sell Markets Mojo
Additional Considerations Required While Assessing Bhagiradha Chemicals & Industries' (NSE:BHAGCHEM) Strong Earnings simplywall.st
Bhagiradha Chemicals schedules analyst meet on May 27 scanx.trade
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Bhagiradha Chemicals & Industries Limited is an India-based company, which is engaged in manufacture of crop protection chemicals. The Company has a portfolio of 30 products spread across various insecticides, herbicides and fungicides and other intermediates. The Company operates through the manufacturing and sales of the crop care chemicals segment. Its insecticides include Chlorpyrifos, Chlorpyrifos-Methyl, Diafenthiuron, Fipronil, Dinotefuran, Thiamethoxam, Imidacloprid and Pymetrozine. Its herbicides include Triclopyr, Clodinafop-propargyl and Cloquintocet-Mexyl (Safener). The Company's manufacturing unit is located near the eastern coastal town of Ongole, 300 kilometers north of Chennai. It has an annual capacity of 3,250 metric tons per annum for the manufacture of various technical grade insecticides, herbicides, and fungicides. It has its footprint in various countries, including Argentina, Korea, Australia, Malaysia, Belgium, Mexico, Brazil, New Zealand, Chile, and others.
Bhagiradha Chemicals & Industries Ltd has the symbol BHAGCHEM and ISIN - INE414D01027.
Bhagiradha Chemicals & Industries Ltd is currently trading at INR 247.30.
Bhagiradha Chemicals & Industries Ltd has a year high of INR 316.90 and a year low of INR 170.60.
Bhagiradha Chemicals & Industries Ltd has a market capitalization of INR 3,539.50 crore.
Bhagiradha Chemicals & Industries Ltd has a P/E ratio of 137.17.
Bhagiradha Chemicals & Industries Ltd has a dividend yield of 0.05%.
Bhagiradha Chemicals & Industries Ltd has revenue of INR 535.94 crore, net income of INR 18.17 crore, and EPS of INR 2.12.
Bhagiradha Chemicals & Industries Ltd has a book value of NA.
Bhagiradha Chemicals & Industries Ltd has a debt-to-equity ratio of NA.
Bhagiradha Chemicals & Industries Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 6.60.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.